Loading clinical trials...
Loading clinical trials...
The phase I/II trial assess the safety and efficacy of a new positron emission tomography (PET) test for early diagnosis of lung cancer. This study uses PET and Me-4FDG new glucose tracer (alpha-methy...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
NCT05528458 · Lung Adenocarcinoma
NCT07479095 · Lepidic-Predominant Lung Adenocarcinoma, Lung Adenocarcinoma
NCT05198830 · Lung Adenocarcinoma, Lung Large Cell Carcinoma, and more
NCT07219251 · Lung Cancer (NSCLC), Lung Adenocarcinoma, and more
NCT07235280 · Lung Adenocarcinoma, Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8, and more
Yesenia Calzada
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions